Search results
Results will auto-populate based on filter selection.
614
Found 614 result(s)
Update July 26, 2023
The first phase of our consultation began on June 8, 2023 and closed on July 21, 2023. We appreciate all the feedback received, which overwhelmingly…
Each year, we are required under the Workplace Safety and Insurance Act to conduct a value-for-money audit. The latest audit focused on the dispute resolution, appeals and…
Most Ontario businesses that have employees (including family members and sub-contractors) must register with us. We provide workplace insurance to 16 diverse industries and…
On this page:
1. Introduction
1.1. Background
2. Occupational disease legislative and policy scheme…
The Drug Advisory Committee was established in 2007 to guide WSIB on which drugs to include in our drug benefit plan as well as the medical conditions and criteria needed for…
Each year, we are required under the Workplace Safety and Insurance Act (WSIA) to have an external firm review the cost, efficiency, and effectiveness of one of our programs…
Onabotulinumtoxin-A, incobotulinumtoxin-A, abobotulinumtoxin-A
Indication(s)
OnabotulinumtoxinA (Botox®) is indicated for the treatment of blepharospasm/VII…
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection
Indication(s)
Buprenorphine/naloxone sublingual (SL) tablet (…